Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Rev. méd. Chile ; 147(8): 1036-1041, ago. 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-1058640

ABSTRACT

Hematological neoplasms are tumors of cells in different states of maturation and differentiation. Since monoclonal gammopathies (MG) refer to B mature lymphocyte neoplasms, lymphogenesis should be well known. We must keep in mind that the last stage of maturation of these lymphocytes is the plasma cell. This is how a MG could appear in the context of a plasma cell neoplasm, such as multiple myeloma or amyloidosis, but also in relation to a lymphoma. A monoclonal peak is produced by mature B lymphocytes or plasma cells that secrete a monoclonal protein (Immunoglobulin), and represents a MG. But it must be emphasized that, in the correct clinical context, a hypogammaglobulinemia can represent a MG as well. Another important point is the understanding and interpretation of requested tests, such as protein electrophoresis (PEP), immunofixation (IFx) or serum free light chains (sFLC). The current MG screening panel includes these three studies (PEF, IFx, sFLC), although a simpler panel measuring PEF and sFLC has also been proposed, but not yet formally validated. Therefore, screening done only with PEP is insufficient.


Subject(s)
Humans , Paraproteinemias/blood , Paraproteins/analysis , Neoplasms, Plasma Cell/blood , Paraproteinemias/diagnosis , Blood Protein Electrophoresis/methods , B-Lymphocytes/metabolism , Neoplasms, Plasma Cell/diagnosis
2.
The Korean Journal of Laboratory Medicine ; : 18-21, 2011.
Article in English | WPRIM | ID: wpr-30867

ABSTRACT

Monoclonal gammopathy occurs in one-third of the patients with mucosa-associated lymphoid tissue lymphoma (MALT lymphoma). However, monoclonal gammopathy has been rarely reported in Korea. Paraprotenemia accompanying MALT lymphoma is strongly correlated with involvement of the bone marrow, and this involvement leads to the progression of the disease. Here, we present a case of a 66-yr-old man diagnosed with IgM monoclonal gammopathy and stage IV extranodal marginal zone lymphoma of the small intestine, with the involvement of the bone marrow.


Subject(s)
Aged , Humans , Male , Antineoplastic Agents/therapeutic use , Bone Marrow/pathology , Drug Therapy, Combination , Electrophoresis, Polyacrylamide Gel , Immunoglobulin M/analysis , Intestinal Neoplasms/complications , Lymphatic Metastasis , Lymphoma, B-Cell, Marginal Zone/complications , Neoplasm Staging , Paraproteinemias/blood , Positron-Emission Tomography , Tomography, X-Ray Computed
3.
Journal of Veterinary Science ; : 359-361, 2010.
Article in English | WPRIM | ID: wpr-197689

ABSTRACT

An 8-year-old male Austrian Pinscher and a 14-year-old male Golden Retriever were presented for evaluation due to unexplainable high fructosamine values despite euglycemia and epistaxis in combination with polydipsia/polyuria, respectively. Blood analysis revealed severe hyperglobulinemia, hypoalbuminemia and markedly elevated fructosamine concentrations in both dogs. Multiple myeloma with IgA-monoclonal gammopathy was diagnosed by serum and urine electrophoresis including immunodetection with an anti-dog IgA antibody and bone marrow aspirations. Diabetes mellitus was excluded by repeated plasma and urine glucose measurements. Fructosamine values were positively correlated with globulin, but negatively correlated with albumin concentrations. These cases suggest that, as in human patients, monoclonal IgA gammopathy should be considered as a possible differential diagnosis for dogs with high fructosamine concentrations.


Subject(s)
Animals , Dogs , Male , Blood Proteins/analysis , Dog Diseases/blood , Fructosamine/blood , Immunoglobulin A/metabolism , Melphalan/therapeutic use , Multiple Myeloma/complications , Myeloablative Agonists/therapeutic use , Paraproteinemias/blood
4.
Arq. bras. oftalmol ; 68(4): 539-541, jul.-ago. 2005. ilus
Article in English | LILACS | ID: lil-417797

ABSTRACT

Relatar um caso de depósito corneano de cobre em ambos os olhos a nível da membrana de Descemet associado a gamopatia monoclonal de significância indeterminada (GMSI). Paciente feminina, 49 anos, leucodérmica, apresentando depósito corneano de aspecto marrom-ouro a nível da membrana de Descemet em ambos os olhos. Exame sistêmico revelou cobre sérico elevado, ceruloplasmina sérica normal, e proteína total normal. Eletroforese de proteínas séricas demonstrou um pico único na região gama (proteína M = 11 g/l). Análise citométrica de aspirado medular evidenciou uma população de células plasmáticas monoclonais de aproximadamente 2% do total de células medulares consistente com o diagnóstico de gamopatia monoclonal de significância indeterminada. Depósitos de cobre a nível da membrana de Descemet podem ser encontrados em pacientes com gamopatia monoclonal de significância indeterminada.


Subject(s)
Humans , Female , Middle Aged , Copper/analysis , Monoclonal Gammopathy of Undetermined Significance/diagnosis , Descemet Membrane/chemistry , Paraproteinemias/diagnosis , Blood Protein Electrophoresis , Copper/blood , Monoclonal Gammopathy of Undetermined Significance/blood , Descemet Membrane/metabolism , Paraproteinemias/blood
5.
Rev. méd. Chile ; 123(12): 1499-504, dic. 1995. tab
Article in Spanish | LILACS | ID: lil-173290

ABSTRACT

Most patients with multiple myeloma have an abnormal band in the gamma region of protein electrophoresis. To correlate the clinical diagnosis with patterns of protein electrophoresis. Retrospective analysis of all protein electrophoresis or immunoglobulin quantification requested during 1992 and review of clinical charts of patients. During 1992, 553 protein electrophoresis were requested. Of these, 344 were repetitions and 209 came from patients seen for the first time. Among the latter, we found a monoclonal component in 40. Of these 40 patients, 35 had a multiple myeloma, one had a plasmocytoma and four a non-Hodgkin lymphoma. 14 patients with diagnosis of myeloma did not have a monoclonal component in protein electrophoresis. These figures resulted in a 71 percent sensitivity and 97 percent specificity for monoclonal components in the diagnosis of multiple myeloma. The monoclonal component of patients with myeloma was characterized as IgG in 29 (60 percent), IgA in 5 (10 percent) and IgM in one. A monoclonal component present in a protein electrophoresis has a high diagnostic accuracy for multiple myeloma


Subject(s)
Humans , Male , Female , Paraproteinemias/blood , Blood Protein Electrophoresis/methods , Multiple Myeloma/blood , Hypergammaglobulinemia/diagnosis , Neoplasms/blood
SELECTION OF CITATIONS
SEARCH DETAIL